Osseous fragility in Marshall-Smith syndrome

Am J Med Genet A. 2003 Jun 1;119A(2):218-22. doi: 10.1002/ajmg.a.10173.

Abstract

Marshall-Smith syndrome is characterized by accelerated osseous maturation, craniofacial anomalies, failure to thrive, psychomotor delay, hypotonia, pulmonary dysfunction, and limited life expectancy. We describe a 7-year-old girl who, in addition to meeting these criteria for Marshall-Smith syndrome, had multiple fractures and skeletal anomalies. The purpose of this report is to draw attention to Marshall-Smith syndrome as one of the skeletal dysplasias characterized by osseous fragility.

MeSH terms

  • Age Determination by Skeleton
  • Antineoplastic Agents / pharmacology
  • Bone Diseases, Developmental / drug therapy
  • Bone Diseases, Developmental / genetics
  • Bone Diseases, Developmental / physiopathology*
  • Bone and Bones / injuries
  • Bone and Bones / physiopathology*
  • Child
  • Child, Preschool
  • Diphosphonates / pharmacology
  • Female
  • Fractures, Bone / physiopathology
  • Humans
  • Infant
  • Pamidronate

Substances

  • Antineoplastic Agents
  • Diphosphonates
  • Pamidronate